Search research articles
Contact Us
Filters
Showing results (181-190 of 183) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 183 results.
Medicine
|
July 2, 2015
Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based Cohort of 98,876 Patients in Taiwan
Yu-Ting Lee, Chia-Jen Liu, Yu-Wen Hu, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
May 18, 2026
Tackling similarities and differences in global practice guidelines for gastric cancer: a review on the latest Taiwan guidelines with Asia-Pacific, European and US guidelines
Chih-Chieh Yen, I-Chen Wu, Cheng-Chan Yu, et al.
The Lancet. Gastroenterology & Hepatology
|
June 1, 2024
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
Do-Youn Oh, Aiwu Ruth He, Mohamed Bouattour, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 183) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 183 results.
Medicine
|
July 2, 2015
Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based Cohort of 98,876 Patients in Taiwan
Yu-Ting Lee, Chia-Jen Liu, Yu-Wen Hu, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
May 18, 2026
Tackling similarities and differences in global practice guidelines for gastric cancer: a review on the latest Taiwan guidelines with Asia-Pacific, European and US guidelines
Chih-Chieh Yen, I-Chen Wu, Cheng-Chan Yu, et al.
The Lancet. Gastroenterology & Hepatology
|
June 1, 2024
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
Do-Youn Oh, Aiwu Ruth He, Mohamed Bouattour, et al.
Page
of 19